IL122802A0 - Gene preparations - Google Patents

Gene preparations

Info

Publication number
IL122802A0
IL122802A0 IL12280296A IL12280296A IL122802A0 IL 122802 A0 IL122802 A0 IL 122802A0 IL 12280296 A IL12280296 A IL 12280296A IL 12280296 A IL12280296 A IL 12280296A IL 122802 A0 IL122802 A0 IL 122802A0
Authority
IL
Israel
Prior art keywords
gene preparations
preparations
gene
desired genes
carriers
Prior art date
Application number
IL12280296A
Other languages
English (en)
Original Assignee
Koken Kk
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Kk, Sumitomo Pharma filed Critical Koken Kk
Publication of IL122802A0 publication Critical patent/IL122802A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12280296A 1995-07-03 1996-07-02 Gene preparations IL122802A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16774495 1995-07-03
PCT/JP1996/001824 WO1997002047A1 (fr) 1995-07-03 1996-07-02 Preparations de genes

Publications (1)

Publication Number Publication Date
IL122802A0 true IL122802A0 (en) 1998-08-16

Family

ID=15855313

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12280296A IL122802A0 (en) 1995-07-03 1996-07-02 Gene preparations
IL122802A IL122802A (en) 1995-07-03 1997-06-20 Continuous release of a genetic preparation in the form of a gel

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL122802A IL122802A (en) 1995-07-03 1997-06-20 Continuous release of a genetic preparation in the form of a gel

Country Status (12)

Country Link
EP (1) EP0844004B1 (ko)
KR (1) KR100431779B1 (ko)
CN (1) CN1230205C (ko)
AT (1) ATE372787T1 (ko)
AU (1) AU704694B2 (ko)
CA (1) CA2225998C (ko)
DE (1) DE69637243T2 (ko)
ES (1) ES2293648T3 (ko)
IL (2) IL122802A0 (ko)
NZ (1) NZ311175A (ko)
TW (1) TW577747B (ko)
WO (1) WO1997002047A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543994B1 (ko) * 1996-04-12 2006-10-31 더 리젠츠 오브 더 유니버시티 오브 미시건 상처치료를위한invivo유전자전달방법
EP1623723A3 (en) 1998-05-22 2006-05-10 Dainippon Sumitomo Pharma Co., Ltd. Stable gene formulations
US6787359B1 (en) 1998-07-01 2004-09-07 Takara Shuzo Co., Ltd. Gene transfer methods
JP5118285B2 (ja) * 2000-06-20 2013-01-16 大日本住友製薬株式会社 オリゴヌクレオチド導入製剤
EP3251722B1 (en) * 2001-04-20 2020-06-17 ALZA Corporation Microprojection array having a beneficial agent containing coating and method of forming the coating thereon
US7963935B2 (en) * 2001-04-20 2011-06-21 Alza Corporation Microprojection array having a beneficial agent containing coating
ES2324525T3 (es) * 2001-06-20 2009-08-10 Dainippon Sumitomo Pharma Co., Ltd. Metodo para promover transferencia de acidos nucleicos.
EP1480656A4 (en) * 2002-02-15 2007-07-18 Res Dev Foundation ADENOVIRAL TRANDUCTION INDUCED BY HYALURONIC ACID
WO2005077333A2 (en) * 2004-02-10 2005-08-25 University Of Florida Research Foundation, Inc. Gel-based delivery of recombinant adeno-associated virus vectors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657658B2 (ja) * 1985-04-11 1994-08-03 住友製薬株式会社 徐放性製剤
JPS60126217A (ja) * 1983-12-14 1985-07-05 Sumitomo Chem Co Ltd 長期徐放性製剤
JPH0759522B2 (ja) * 1985-12-27 1995-06-28 住友製薬株式会社 徐放性製剤の製造法
DE3802158A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Vorrichtung zur applikation von implantaten
JP3187410B2 (ja) * 1989-08-10 2001-07-11 住友製薬株式会社 脳内投与用徐放性製剤
JP2789115B2 (ja) * 1989-09-07 1998-08-20 株式会社高研 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法
WO1992020400A1 (en) * 1991-05-24 1992-11-26 Sumitomo Pharmaceuticals Company, Limited Instrument for applying pharmaceutical to inside of brain
EP0695170A4 (en) * 1993-04-19 1998-08-19 Medisorb Technologies Internat LONG-TERM TREATMENT BY SLOW DELIVERY OF ANTISENSE-OLIGODEOXY-RIBONUCLEOTIDES FROM BIODEGRADABLE MICROPARTICLES
AU710504B2 (en) * 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system

Also Published As

Publication number Publication date
CA2225998A1 (en) 1997-01-23
NZ311175A (en) 1999-11-29
CA2225998C (en) 2010-11-02
ES2293648T3 (es) 2008-03-16
WO1997002047A1 (fr) 1997-01-23
TW577747B (en) 2004-03-01
KR100431779B1 (ko) 2004-09-04
ATE372787T1 (de) 2007-09-15
EP0844004A1 (en) 1998-05-27
AU704694B2 (en) 1999-04-29
CN1193916A (zh) 1998-09-23
EP0844004A4 (en) 2000-03-15
DE69637243T2 (de) 2008-06-19
AU6243696A (en) 1997-02-05
EP0844004B1 (en) 2007-09-12
CN1230205C (zh) 2005-12-07
KR19990028522A (ko) 1999-04-15
DE69637243D1 (de) 2007-10-25
IL122802A (en) 2007-09-20

Similar Documents

Publication Publication Date Title
AU5153296A (en) Vectors for gene delivery
AU699706C (en) Improved vectors for gene therapy
EP0625049A4 (en) EX VIVO GENTRANSFER.
KR100253672B1 (en) Methods and applications for efficient genetic suppressor elements
AU6617898A (en) An antisense oligonucleotide preparation method
EP0710123A4 (en) ADENOVIRUS VECTORS FOR GENE THERAPY
EP0633943A4 (en) GENTHERAPY USING TARGETED VIRAL VECTORS.
ES2085966T3 (es) Mecanismos geneticos de supresion de tumores.
HUP9700428A3 (en) Targetcell-specific vectors for inserting genes, pharmaceuticals comprising such vectors and their use
EP0773296A4 (en) SECRETION SIGNAL GENE AND EXPRESSION VECTOR COMPRISING THIS SIGNAL
PT1584682E (pt) Regulação da expressão do gene bcl-2
AU3169495A (en) Gene therapy for restenosis using an adenoviral vector
IL122802A0 (en) Gene preparations
AUPN631495A0 (en) Vaccine and biological vector(I)
AU5590394A (en) Transglutaminase gene
AUPN631395A0 (en) Vaccine and biological vector(II)
AU4987396A (en) Cradle support handler
AU5703796A (en) Improved retroviral vectors, especially suitable for gene th erapy
IL120076A (en) Substantially pure dna sequence containing the dysautonomia gene
AU4839493A (en) Portable intron as an insertion vector for gene insertion
IL109333A0 (en) Genetic stabilizing elements
AU4941096A (en) Self-deleting vectors for gene therapy
GB9506051D0 (en) Gene expression
EP0658196A4 (en) GENE INSERTION BY DIRECT -i (IN VITRO) LINK.
FR2702179B1 (fr) Support adaptable pour liste d'achats.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed